Free self-service kiosk provides eye exams

Article

EyeSite, a free, interactive, self-service vision screening booth developed by Bart Foster of SoloHealth, has been launched, with the first kiosk taking residence in a Wal-Mart store in Georgia, US.

EyeSite, a free, interactive, self-service vision screening booth developed by Bart Foster of SoloHealth, has been launched, with the first kiosk taking residence in a Wal-Mart store in Georgia, US.

More than 6000 Wal-Mart customers have used the booth since its installation this spring, more than 30% of whom had never previously been examined by an eyecare professional. Of the customers undergoing the simple eye test, 80% were recommended to follow up with a visit to an eyecare professional.

As well as providing eye tests, the EyeSite booth can provide information about common but often undiagnosed conditions such as glaucoma. The goal of the kiosk is not to replace a traditional eye examination but to assess distance and near vision and potentially refer the user to a relevant healthcare professional in the vicinity. SoloHealth plans to launch the booth in more communities in the near future.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.